european medicines agency glp-1 vision loss recommendation november 2025 Ozempic has 'very rare' sight side effect, EU drugs regulator finds – POLITICO Safety and Tolerability of Glucagon-Like

The median (IQR) duration of HPN and weekly calories was 42.5 (15.8-62.3) months and 6647kcal (3476.3-8471.3) respectively

Investigations into biased agonism, where medications are designed to selectively activate beneficial GLP-1 receptor pathways while minimizing those that cause side effects, could eventually produce GLP-1 medications with significantly reduced dry mouth profiles

$297/mo for monthly plans GLP-1 agonist 15% (68 weeks) 0.20 mg weekly 2.4 mg weekly Tirzepatide $332 / mo Billed Quarterly, Delivered Quarterly

Questions to ask your provider include: Do you customise the dosage based on individual patient needs